General Biotechnology

When Patents Persist What if that patent you’re paying royalties on suddenly gets extended? Have you negotiated the best licensing […]

Amgen’s Cannibalistic Ways If you don’t think that Amgen is excited about its future, check out what the company is

Amgen’s Cannibalistic Ways If you don’t think that Amgen is excited about its future, check out what the company is

FDA Chief Eyes Path for Copycat Biotech Drugs Food and Drug Administration Commissioner Mark McClellan said on Friday it may

Boston’s Biotech Moment The future is moving out of dusty library stacks and into pristine laboratories on both sides of

Boston’s Biotech Moment The future is moving out of dusty library stacks and into pristine laboratories on both sides of

Professor, Biotech Butt Heads Ignacio Chapela, an ecologist known for his controversial research on genetically modified corn, is turning a

Tech Transfer: The Ties That Bind Did you know that the lack of an IPO window, depressed market conditions and

Drug companies make patent concessions AIDS activists hailed a breakthrough agreement with two of the largest drug companies in South

Dutch Official Calls on Europe to Open Markets to Biotech Foods Europe should no longer exclude genetically modified agricultural products